Deepverge has published initial data from its ongoing Phase III clinical studies for the detection of SARS-CoV-2 from samples of breath condensate and identification of confirmed COVID-19 positive patients.
Microtox ® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples
Nomination for Outstanding New Environmental Monitoring Product of the Year in China 2020
Deepverge has today announced its appointment of a former IBM Legal Counsel as inhouse lawyer and Company Secretary. Fiona Joyce’s engagement is seen as an important signal from the Board,
Deepverge (formerly Integumen) is a vertically integrated business, collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science.
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a five year agreement
